insights_auto
Why is ABVX up ६.८०%?
Dive Deeperchevron_right
ABVX:EPA
Abivax SA
€ ८३.२५
arrow_upward
+६.८०%(+५.३०) 1D
अक्टोबर २०, १७:३५:१८ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
€ ७८.५०
High
€ ८३.६०
Low
€ ७८.००
Mkt. cap
६.९५ अरब
Avg. vol.
१.२२ लाख
Volume
०.००
52-wk high
€ १३९.००
52-wk low
€ ६०.४५
EPS
-€ ५.२०
Shares outstanding
८.७५ करोड
No. of employees
९८
Open
€ ७८.५०
High
€ ८३.६०
Low
€ ७८.००
Mkt. cap
६.९५ अरब
Avg. vol.
१.२२ लाख
Volume
०.००
52-wk high
€ १३९.००
52-wk low
€ ६०.४५
EPS
-€ ५.२०
Shares outstanding
८.७५ करोड
No. of employees
९८
News stories
From web sources and news partners
StockStory
·
५ मिनेट पहिले
Pool (POOL) Reports Earnings Tomorrow: What To Expect
PR Newswire
·
१ घण्टा पहिले
FF EAI Robotics Ecosystem Inc. Announces Details for Its Listing Ceremony and Nasdaq Investor Day, Taking Place on Monday, Oct. 26, at Nasdaq's MarketSite in NYC
The Chronicle-Journal
·
३० मिनेट पहिले
What To Expect From Nasdaq’s (NDAQ) Q3 Earnings
Yahoo Finance
·
१ घण्टा पहिले
How Long Could You Wait for the S&P 500 to Recover From a 10% Drop?
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees९८
Founded२०१३ डिसेम्बर ४
Headquarters-
Sector-
Websiteabivax.com